P3 Health (PIII): Market Cap to Future Revenue Ratio

Graphic logo of P3 Health Partners Inc. (PIII)

The forward P/S ratio for P3 Health Partners Inc. (PIII) exhibits volatility, as domestic US demand is offset by risks of global raw material supply chain disruptions. The current status is 0.00. The business relies on coordinating assistance for retirees through insurance funds, yet the high cost of elderly care is forcing the company to radically overhaul its underwriting model to stabilize its finances.

P3 Health Partners, Inc. - PIII Price-to-Projected Revenue Ratio (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for p3hp.org (PIII)

- price and consensus price forecast:
Price Performance Chart P3 Health Partners|PIII - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Value P3 Health Partners Inc.|PIII - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share P3 Health Partners|PIII - Company Book Value|Market Value to Book Value Ratio p3hp.org|PIII - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Aggregate Debt to Capital P3 Health Partners Inc.|PIII - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital P3 Health Partners|PIII - Company Total Debt|Debt to Net Assets Ratio P3 Health Partners Inc.|PIII - Company Long-Term Debt|Current Liabilities P3 Health Partners|Quick Ratio p3hp.org
- financial results and valuation multiples details:
PIII - Company Net Income|Expected Net Income P3 Health Partners Inc.|PIII - Price to Earnings Ratio|Market Cap to Future Earnings Ratio P3 Health Partners|PIII - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation P3 Health Partners Inc.|PIII - Operating profit EBITDA|Net earnings per one share for the last twelve months P3 Health Partners|PIII - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months p3hp.org|PIII - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year P3 Health Partners Inc.
- sales revenue and business income indicators:
PIII - Company Sales|Company Future Revenue P3 Health Partners|PIII - P/S Multiple|Market Cap to Expected Sales Ratio P3 Health Partners Inc.
Analysis of all company metrics:PIII, P3 Health
Signature product of P3 Health Partners, Inc.

For investors, the valuation of P3 Health Partners Inc. (PIII) depends on the Value-Based Care ecosystem's ability to scale its Medicare Advantage network amid strict CMS rate regulations. By analyzing the forward P/S chart, one can compare the company's market value with expected revenue to determine if the asset is overvalued or to identify critical operational risks through abnormally low multiple values.

Who P3 Health Partners Inc. competes with

Forward Price to Sales HCA Healthcare|Forward P/S Multiple Tenet Healthcare Corp THC|FMS (Fresenius Medical Care Corp) - Market Cap to Future Revenue Ratio|SOLV - Forward P/S Multiple|EHC: Forward P/S Multiple|UHS (Universal Health Services, Inc.) - Price-to-Projected Revenue Ratio|Price-to-Projected Revenue Ratio DaVita|Forward Price-to-Revenue Multiple RadNet Inc (RDNT)|Price to Expected Revenue Ratio Option Care Health Inc|Forward P/S Multiple Surgery Partners Group (SGRY)|Forward Price to Sales Premier, Inc.|EYE - Forward Price-to-Revenue Multiple|Forward Price to Sales Progyny (PGNY)|ARDT: Price-to-Projected Revenue Ratio|Future Price to Revenue Select Medical Corp (SEM)|Astrana Corp (ASTH) - Forward P/S Multiple|MD (Pediatrix Corp) - Forward P/S Multiple|Price-to-Projected Revenue Ratio USPH|The Pennant Group (PNTG) - Forward Price to Sales|Forward Price-to-Revenue Multiple Organogenesis Holdings Inc. ORGO|Price to Expected Revenue Ratio Nutex Health Corp (NUTX)|Auna Corp - Price-to-Projected Revenue Ratio|SBC Medical Corp (SBC) - Market Cap to Projected Revenue|EOLS - Forward P/S Multiple|Market Cap to Future Revenue Ratio CYH|SKIN (BeautyHealth) - Price-to-Projected Revenue Ratio|MDWD - Forward Price to Sales|Price-to-Projected Revenue Ratio BTMD|JYNT (The Joint Corp.) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple docgo.com DCGO|Forward Price to Sales Gain Therapeutics|Forward P/S Multiple EUDA Health Holdings EUDA|Market Cap to Expected Sales Ratio BMGL (Basel Medical Group Limited)|CLGN: Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue Cuprina Holdings (Cayman) Ltd|concordmedical.com (CCM) - Forward P/S Multiple|Forward Price-to-Revenue Multiple AMS|Forward Price-to-Revenue Multiple MEDIROM Healthcare Group Inc. (MRM)|ALBT (Avalon GloboCare) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio DHAI (DIH Group)|Longevity Health Holdings (XAGE) - Future Price to Revenue|Forward P/S Multiple newgenivf.com NIVF|Market Cap to Expected Sales Ratio ATIP (ATI Physical Therapy Corp)|CMAX - Forward P/S Multiple|Kindly MD Corp - Market Cap to Expected Sales Ratio|ModivCare Corp (MODV) - Forward P/S Multiple|NVOS: Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple SunLink Health Systems, Inc (SSY)|Price to Expected Revenue Ratio IMAC Holdings